Online citations, reference lists, and bibliographies.

Comparison Of Four Staining Methods On The Detection Of Neuritic Plaques

H. Wisniewski, G. Y. Wen, K. Kim
Published 2004 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
SummaryThe sensitivities of four staining methods for detecting the presence of neuritic plaques in the normal aging. Alzheimer disease (AD) and Down's syndrome (DS) brains were compared. The Bielschowsky method and immunostaining with monoclonal antibody (4G8, IgG2b) to β-amyloid revealed the highest numbers of plaques. The thioflavin S-staining method showed about 38%–70% of plaques as shown by the Bielschowsky method. The Bodian method is the least sensitive method revealing about 26%–39% of plaques as compared with the Bielschowsky method. In the first part of this study, serial sections (6 μm) of the plaques from AD and DS brains were cut and stained with Bielschowsky, thioflavin S and Bodian methods, respectively. In the second part, Bielschowsky and immunostaining methods were used to stain serial sections (6 μm) of plaques from the same block of brain tissue. A Zeiss Axiophot fluorescence microscope, coupled with the Cambridge Quantiment 970 and Zeiss Videoplan computerized image analyzers, was used to quantify the number of plaques. Both Bielschowsky and immunostaining methods revealed the presence of both the peripheral zone (halo) and the central core of a classical plaque and resulted in the highest plaque counts. The central core of the thioflavin S-stained plaques were still clearly present, but the peripheral zone was barely visible. In Bodian stain, however, both central core and peripheral zone were poorly stained and not detectable by computer. They were quantified by human eye observation. The Bielschowsky method and immunostaining with pretreatment with formic acid are, therefore, the most sensitive methods showing the highest contrast of plaque image and thus facilitate the quantification of plaque by computer. However, Bielschowsky method is not a specific method for plaques. It stains neurofibrillary tangles and blood vessels regardless of whether they have amyloid deposits or not. Immunostaining is a sensitive and specific method for amyloid and exhibits low background staining. It confirmed that all Bielschowsky-stained plaques contained amyloid deposit.
This paper references
Silver staining of Alzheimer's neurofibrillary changes by means of physical development.
F. Gallyas (1971)
10.1007/BF00686078
An immunocytochemical comparison of cytoskeletal proteins in aluminum-induced and Alzheimer-type neurofibrillary tangles
D. Munoz-Garcia (1986)
10.1001/archneur.1970.00480300098017
Amyloidosis Cause and Manifestation of Senile Deterioration.
G. Kirschberg (1970)
Comparison of staining methods for neuritic plaque detection 27 amyloid plaques in striatum and diencephalon
P Schwartz (1970)
10.1111/j.1365-2990.1986.tb00677.x
A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles.
T. Yamamoto (1986)
Die Silberimpregnation der Neurofibrillen
M Bielschowsky (1904)
Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide
KS Kim (1988)
10.1111/j.1532-5415.1981.tb01758.x
Quantitative clinicopathologic study of senile dementia.
J. Kurucz (1981)
10.1007/978-1-4612-5058-6_20
Neuropathology of the Aging Brain and Dementia of the Alzheimer Type
H. Wiśniewski (1985)
10.1007/BF00690393
Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon
R. Rudelli (2004)
10.1007/BF00687893
Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type
P. Delaère (2004)
10.1002/ana.410100209
Some morphometric aspects of the brain in senile dementia of the alzheimer type
R. Terry (1981)
Die Silberimpregnation der Neurofibrillen
M Bielschowsky (1904)
10.1007/BF00689591
A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated byβ protein immunostaining
H. Yamaguchi (1988)
10.1007/978-1-4612-5058-6_20
Neuropathology of the Aging Brain and Dementia of the Alzheimer Type
Henryk M. Wiśniewski (1985)
Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids.
T. Kitamoto (1987)
10.1007/BF00693783
Quantitative assessment of the density of neurofibrillary tangles and senile plaques in senile dementia of the Alzheimer type. Comparison of immunocytochemistry with a specific antibody and Bodian's protargol method
C. Duyckaerts (2004)
Manual of histologic staining methods of the Armed forces institute of pathology
L. Luna (1968)
10.1097/00005072-198705000-00025
STAINING DIFFERENCES OF NEURITIC PLAQUES BY BIELSCHOWSKY, THIOFLAVIN S AND BODIAN METHODS: 18
Guang Y. Wen (1987)
10.1001/archneur.1985.04060100083029
Diagnosis of Alzheimer's disease.
Z. Khachaturian (1985)



This paper is referenced by
10.3389/fnagi.2015.00047
Organotypic vibrosections from whole brain adult Alzheimer mice (overexpressing amyloid-precursor-protein with the Swedish-Dutch-Iowa mutations) as a model to study clearance of beta-amyloid plaques
C. Humpel (2015)
A b peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer ' s disease
C. Janus ()
10.1007/BF00308476
A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease
P. Vallet (2004)
10.1074/jbc.M706316200
The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.
Ramiro E. Llovera (2008)
10.1007/s00401-004-0947-7
Silver stains distinguish tau-positive structures in corticobasal degeneration/progressive supranuclear palsy and in Alzheimer’s disease—Comparison between Gallyas and Campbell-Switzer methods
T. Uchihara (2004)
10.1016/j.neurobiolaging.2007.03.007
Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: Relationship with the progression of Alzheimer's disease
Afia Akram (2008)
10.1093/CERCOR/BHL140
Increased cortical expression of two synaptogenic thrombospondins in human brain evolution.
M. Cáceres (2007)
10.1007/BF00293394
Presence of non-fibrillar amyloid β protein in skin biopsies of Alzheimer's disease (AD), Down's syndrome and non-AD normal persons
G. Y. Wen (1994)
Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice.
Jiong Shi (2002)
10.1177/1533317510382892
Morphological Changes of the Human Purkinje Cells and Deposition of Neuritic Plaques and Neurofibrillary Tangles on the Cerebellar Cortex of Alzheimer’s Disease
I. Mavroudis (2010)
10.1016/S0197-4580(01)00316-5
Optimization of techniques for the maximal detection and quantification of Alzheimer’s-related neuropathology with digital imaging
B. Cummings (2002)
Are routine methods good enough to stain senile plaques and neurofibrillary tangles in different brain regions of demented patients?
Paraskevi Mavrogiorgou (2011)
10.1007/BF00296188
Analysis of staining methods for different cortical plaques in Alzheimer's disease
G. Halliday (1994)
10.1016/j.expneurol.2004.12.005
Stereologic analysis of hippocampal Alzheimer's disease pathology in the oldest-old: Evidence for sparing of the entorhinal cortex and CA1 field
A. V. Gunten (2005)
10.1007/BF00334887
Comparison of silver stainings and immunohistology for the detection of neurofibrillary tangles and extracellular cerebral amyloid in paraffin sections
A. Rosenwld (1993)
10.1371/journal.pone.0046650
Beneficial Effect of Antibodies against β- Secretase Cleavage Site of App on Alzheimer’s-Like Pathology in Triple-Transgenic Mice
Inna Rabinovich-Nikitin (2012)
10.1016/j.neurobiolaging.2005.02.017
A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain
S. Czasch (2006)
10.1016/j.jcpa.2010.11.004
Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction.
C-H Yu (2011)
10.1016/j.nucmedbio.2020.05.001
Development of a PET radioligand selective for cerebral amyloid angiopathy.
Eric E. Abrahamson (2020)
10.1177/089198879500800211
Comparison of New and Traditional Methods for Detection of Senile Plaques in Alzheimer's Disease
L. S. Raskin (1995)
10.1007/BF00294646
Modified Bielschowsky stain and immunohistochemical studies on striatal plaques in Alzheimer's disease
T. Suenaga (2004)
In vivo two-photon calcium imaging of hippocampal neurons in a mouse model of Alzheimer´s disease
M. A. Busche (2013)
Alzheimer´s disease and apolipoprotein E.A prospective, population-based molecular genetic and neuropathological study of individuals aged 85 years or more
T. Polvikoski (2004)
10.1007/BF00307688
Alzheimer neuropathology in non-Down's syndrome mentally retarded adults
E. Popovitch (1990)
10.25560/30780
Structural biology of bacterial functional amyloid formation
William D. Hawthorne (2015)
10.5812/THRITA.88367
Evaluation of Aβ Deposits in the Hippocampus of a Rat Model of Alzheimer’s Disease After Intravenous Injection of Human Adipose Derived Stem Cells by Immuno- and Thioflavin S-Costaining
Maryam Doshmanziari (2019)
10.1016/j.jneumeth.2018.03.007
A novel histochemical method of simultaneous detection by a single- or double-immunofluorescence and Bielschowsky’s silver staining in teased rat sciatic nerves
Edith Segura-Anaya (2018)
he second layer neurones of the entorhinal cortex and the perforant path in physiological ageing and Alzheimer ' s disease 2
Janusz (2008)
10.1007/BF00294638
Morphological characteristics of senile plaques in familial Alzheimer's disease
E. Iseki (1990)
10.1007/s00401-007-0200-2
Silver diagnosis in neuropathology: principles, practice and revised interpretation
T. Uchihara (2007)
10.1007/BF00571510
Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients
M. Huell (2004)
Self-Organizing3D HumanNeural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer’sDisease Phenotypes
Waseem Khan Raja (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar